116 related articles for article (PubMed ID: 22196654)
1. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
[TBL] [Abstract][Full Text] [Related]
2. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
[TBL] [Abstract][Full Text] [Related]
7. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
10. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
[TBL] [Abstract][Full Text] [Related]
11. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
12. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience.
Li H; Qin Y; Cui Y; Chen H; Hao X; Li Q
Dig Surg; 2011; 28(3):226-31. PubMed ID: 21540611
[TBL] [Abstract][Full Text] [Related]
14. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategy for patients with middle and lower third bile duct cancer.
Todoroki T; Kawamoto T; Koike N; Fukao K; Shoda J; Takahashi H
Br J Surg; 2001 Mar; 88(3):364-70. PubMed ID: 11260100
[TBL] [Abstract][Full Text] [Related]
16. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
[TBL] [Abstract][Full Text] [Related]
17. Liver metastases after curative resection in patients with distal bile duct cancer.
Takao S; Shinchi H; Uchikura K; Kubo M; Aikou T
Br J Surg; 1999 Mar; 86(3):327-31. PubMed ID: 10201773
[TBL] [Abstract][Full Text] [Related]
18. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
19. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]